表紙:血栓管理デバイス (心血管装置):医療機器のパイプライン製品の情勢 (2021年)
市場調査レポート
商品コード
1034490

血栓管理デバイス (心血管装置):医療機器のパイプライン製品の情勢 (2021年)

Clot Management Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

出版日: | 発行: GlobalData | ページ情報: 英文 91 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
血栓管理デバイス (心血管装置):医療機器のパイプライン製品の情勢 (2021年)
出版日: 2021年10月29日
発行: GlobalData
ページ情報: 英文 91 Pages
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の血栓管理デバイスの市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

目次

第1章 目次

第2章 イントロダクション

  • 血栓管理デバイスの概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定承認時期別
  • 現在進行中の治験

第4章 血栓管理デバイス:各企業で現在治験中のパイプライン製品

  • 血栓管理デバイスの企業:治験段階別のパイプライン製品
  • 血栓管理デバイス:治験段階別のパイプライン製品

第5章 血栓管理デバイス:企業・製品概要

  • Adient Medical Inc.
    • パイプライン製品および進行中の治験の概要
  • AngioDynamics Inc
  • AorticLab Sarl
  • APT Medical Inc
  • Boston Scientific Corp
  • Caeli Vascular LLC
  • Capture Vascular Inc
  • Contego Medical LLC
  • CyndRX LLC
  • Inari Medical Inc
  • Interventional & Surgical Innovations, LLC
  • Kaleidoscope
  • Koninklijke Philips NV
  • Lazarus Effect, Inc
  • LeMaitre Vascular Inc
  • Lithotech Medical Ltd
  • Merit Medical Systems Inc
  • MicroPort Endovascular (Shanghai) Co., Ltd.
  • NexGen Medical Systems Inc
  • OsciFlex LLC
  • Penumbra Inc
  • Shenzhen Salubris Pharmaceuticals Co Ltd
  • Shenzhen Tengfu Medical Technology Co Ltd
  • Suzhou Tianhong Shengjie Medical Co Ltd
  • TransMed7 LLC
  • University of Arizona
  • University of California Los Angeles
  • University of Michigan
  • University of Toledo
  • University of Wolverhampton
  • Veniti Inc
  • Vetex Medical Ltd
  • VueKlar Cardiovascular Ltd (Inactive)
  • WaveClear Inc
  • Zylox-Tonbridge Medical Technology Co Ltd

第6章 血栓管理デバイス:昨今の市場動向

第7章 付録

図表

List of Tables

List of Tables

  • Clot Management Devices - Pipeline Products by Stage of Development
  • Clot Management Devices - Pipeline Products by Segment
  • Clot Management Devices - Pipeline Products by Territory
  • Clot Management Devices - Pipeline Products by Regulatory Path
  • Clot Management Devices - Pipeline Products by Estimated Approval Date
  • Clot Management Devices - Ongoing Clinical Trials
  • Clot Management Devices Companies - Pipeline Products by Stage of Development
  • Clot Management Devices - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Clot Management Devices - Pipeline Products by Stage of Development
  • Clot Management Devices - Pipeline Products by Segment
  • Clot Management Devices - Pipeline Products by Territory
  • Clot Management Devices - Pipeline Products by Regulatory Path
  • Clot Management Devices - Pipeline Products by Estimated Approval Date
  • Clot Management Devices - Ongoing Clinical Trials
目次
Product Code: GDME1169EPD

GlobalData's Medical Devices sector report, "Clot Management Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Clot Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing Percutaneous Coronary Intervention and to treat potentially life-threatening complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Clot Management Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Clot Management Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Clot Management Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Clot Management Devices Overview

3 Products under Development

  • 3.1 Clot Management Devices - Pipeline Products by Stage of Development
  • 3.2 Clot Management Devices - Pipeline Products by Segment
  • 3.3 Clot Management Devices - Pipeline Products by Territory
  • 3.4 Clot Management Devices - Pipeline Products by Regulatory Path
  • 3.5 Clot Management Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Clot Management Devices - Ongoing Clinical Trials

4 Clot Management Devices - Pipeline Products under Development by Companies

  • 4.1 Clot Management Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Clot Management Devices - Pipeline Products by Stage of Development

5 Clot Management Devices Companies and Product Overview

  • 5.1 Adient Medical Inc. Company Overview
    • 5.1.1 Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 AngioDynamics Inc Company Overview
    • 5.2.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 AorticLab Sarl Company Overview
    • 5.3.1 AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 APT Medical Inc Company Overview
    • 5.4.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Boston Scientific Corp Company Overview
    • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Caeli Vascular LLC Company Overview
    • 5.6.1 Caeli Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Capture Vascular Inc Company Overview
    • 5.7.1 Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Contego Medical LLC Company Overview
    • 5.8.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 CyndRX LLC Company Overview
    • 5.9.1 CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Inari Medical Inc Company Overview
    • 5.10.1 Inari Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Interventional & Surgical Innovations, LLC Company Overview
    • 5.11.1 Interventional & Surgical Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Kaleidoscope Company Overview
    • 5.12.1 Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Koninklijke Philips NV Company Overview
    • 5.13.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Lazarus Effect, Inc Company Overview
    • 5.14.1 Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 LeMaitre Vascular Inc Company Overview
    • 5.15.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Lithotech Medical Ltd Company Overview
    • 5.16.1 Lithotech Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Merit Medical Systems Inc Company Overview
    • 5.17.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 MicroPort Endovascular (Shanghai) Co., Ltd. Company Overview
    • 5.18.1 MicroPort Endovascular (Shanghai) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 NexGen Medical Systems Inc Company Overview
    • 5.19.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 OsciFlex LLC Company Overview
    • 5.20.1 OsciFlex LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Penumbra Inc Company Overview
    • 5.21.1 Penumbra Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
    • 5.22.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Shenzhen Tengfu Medical Technology Co Ltd Company Overview
    • 5.23.1 Shenzhen Tengfu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview
    • 5.24.1 Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 TransMed7 LLC Company Overview
    • 5.25.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 University of Arizona Company Overview
    • 5.26.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 University of California Los Angeles Company Overview
    • 5.27.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 University of Michigan Company Overview
    • 5.28.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 University of Toledo Company Overview
    • 5.29.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 University of Wolverhampton Company Overview
    • 5.30.1 University of Wolverhampton Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 Veniti Inc Company Overview
    • 5.31.1 Veniti Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Vetex Medical Ltd Company Overview
    • 5.32.1 Vetex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 VueKlar Cardiovascular Ltd (Inactive) Company Overview
    • 5.33.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 WaveClear Inc Company Overview
    • 5.34.1 WaveClear Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
    • 5.35.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Clot Management Devices- Recent Developments

  • 6.1 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
  • 6.2 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
  • 6.3 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
  • 6.4 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
  • 6.5 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
  • 6.6 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
  • 6.7 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer